TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models.
Vascular calcification (VC) is a major risk factor for elevated cardiovascular morbidity/mortality. Underlying this process is osteoblastic signalling within the vessel wall involving complex and interlinked roles for receptor-activator of nuclear factor-κB ligand (RANKL), osteoprotegerin (OPG), and...
Main Authors: | Emma Harper, Keith D Rochfort, Hannah Forde, Colin Davenport, Diarmuid Smith, Philip M Cummins |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5690591?pdf=render |
Similar Items
-
TRAIL inhibits oxidative stress in human aortic endothelial cells exposed to pro‐inflammatory stimuli
by: Hannah Forde, et al.
Published: (2020-10-01) -
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
by: Belinda A Di Bartolo, et al.
Published: (2013-01-01) -
Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
by: Belinda A. Di Bartolo, et al.
Published: (2013-01-01) -
Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL.
by: Belinda A. Di Bartolo, et al.
Published: (2013-01-01) -
RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.
by: Ling-Qing Yuan, et al.
Published: (2011-01-01)